Changeflow GovPing Healthcare & Life Sciences Method for Reducing Host Cell Proteins in Affin...
Routine Notice Added Final

Method for Reducing Host Cell Proteins in Affinity Chromatography

Favicon for changeflow.com USPTO Patent Applications - Peptides (C07K)
Published
Detected
Email

Summary

The USPTO has published a patent application from Genentech, Inc. detailing a method for purifying antibodies by reducing host cell proteins using a low conductivity aqueous solution in affinity chromatography. This application, filed on December 2, 2025, describes a specific purification technique for biopharmaceutical products.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

This document is a USPTO patent application (US20260085090A1) filed by Genentech, Inc. on December 2, 2025. It describes a method for purifying antibodies by reducing host cell proteins through a wash step with a low conductivity aqueous solution during affinity chromatography. The application lists specific inventors and CPC classifications related to peptide and antibody purification.

While this is a patent application and not a regulatory rule, it signifies a new development in biopharmaceutical manufacturing processes. Companies involved in antibody production or purification may find this method relevant for improving product purity and yield. Compliance officers in the pharmaceutical sector should be aware of such innovations as they can influence future manufacturing standards and intellectual property landscapes.

Archived snapshot

Mar 26, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

METHOD FOR THE REDUCTION OF HOST CELL PROTEINS IN AFFINITY CHROMATOGRAPHY

Application US20260085090A1 Kind: A1 Mar 26, 2026

Assignee

Genentech, Inc.

Inventors

Paul MCDONALD, Richard ST. JOHN, Marc Wong, Roberto FALKENSTEIN, Wolfgang KOEHNLEIN, Klaus SCHWENDNER, Bernhard SPENSBERGER, Michael WIEDMANN, Frank ZETTL, Annika KLEINJANS, Carina KOPP, Benjamin TRAN, Ryan ERICKSON

Abstract

The current invention reports a method for purifying an antibody by reducing the content of a host cell protein. The method employs a wash step with a low conductivity aqueous solution in an affinity chromatography.

CPC Classifications

C07K 1/22 C07K 16/18 C07K 16/22 C07K 16/2854 C07K 16/32 C07K 16/36 C07K 2317/14 C07K 2317/31

Filing Date

2025-12-02

Application No.

19406716

View original document →

Get daily alerts for USPTO Patent Applications - Peptides (C07K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
December 2nd, 2025
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260085090A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Drug Manufacturing Biopharmaceutical Purification
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Research & Development
Compliance frameworks
FDA 21 CFR Part 11 GxP
Topics
Intellectual Property Biotechnology

Get alerts for this source

We'll email you when USPTO Patent Applications - Peptides (C07K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!